Previous studies have suggested that the direct (via VLA-4, VCAM-1, CD44, VLA-5, LFA-1, and syndecan-1) and indirect (via soluble factors) interactions between MM plasma cells and BM-MSCs result in constitutive abnormalities in BM-MSCs. This evidence concerns the gene VCAM1 and Miyoshi myopathy.